Experience

Active Biotech AB

• Biotechnology
• 1 - 100 Employee

• Board Member

  • May 2020 - 3 years 8 months

  Lund, Skane County, Sweden Member of the Board of Directors (non-executive director) Chair of the Scientific Committee



Ryvu Therapeutics

• Poland
• Biotechnology
• 100 - 200 Employee

• Board Member

  • Oct 2019 - 4 years 3 months

  Krakow Member of the Supervisory Board (non-executive director) Remuneration Committee, Clinical Development Committee



AG Life Science Consulting GmbH & Co. KG

• Independent Consultant and Owner

  • Mar 2018 - 5 years 10 months

  Alfter (near Bonn), Germany Strategic consulting services for the pharmaceutical industry and academic medicine www.agls-consulting.de



The Cancer Drug Development Forum (CDDF asbl)

• Treasurer and member of the board of directors

  • Jun 2018 - 5 years 7 months

  Brussels Metropolitan Area The CDDF is a non-profit association that brings together experts from academia, the pharmaceutical industry, regulatory authorities (including the EMA and FDA), payers (health technology assessors) and patient advocates to leverage a multi-stakeholder approach and improve the scientific, regulatory and societal environment for the development of innovative cancer drugs. www.cddf.org



Zen Leadership Academy by Hinnerk Polenski

• Germany
• Professional Training and Coaching
• 1 - 100 Employee

• Trainer

  • Sep 2018 - 5 years 4 months

  Buchenberg (Allgäu) Trainer with a focus on leadership, mindfulness and emotional intelligence www.zen-leadership.de



4D pharma plc

• Non-Executive Chairperson

  • Apr 2020 - Mar 2023

  Leeds, England, United Kingdom

• Board Member

  • Jan 2019 - Mar 2023

  Leeds, United Kingdom Independent Non-Executive Director Remuneration Committee, Clinical Development Committee



AvenCell

• United States
• Biotechnology
• 1 - 100 Employee

• Board Member

  • Jul 2021 - Aug 2022

  Cambridge, Massachusetts, United States Member of the Board of Directors (non-executive director) Chair of the Scientific and Regulatory Committee, Audit and Compensation Committee Representative of one of the major shareholders for an agreed period of time.



Celgene

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Vice President, Global Clinical Research & Development

  • Apr 2016 - Feb 2018

  Summit, NJ, USA Head Clinical Research & Development in Hematology-Oncology. Portfolio development, drug development strategy, alliance management, regulatory strategy and submissions.

• Corporate Vice President, Clinical Research and Development

  • Jan 2015 - Apr 2016

  Summit, NJ, United States of America Therapeutic Area Head for Myeloid Diseases (Acute Myeloid Leukemia, Myelodysplastic Syndromes, Thalassemia) in Clinical Research & Development

• Vice-President Medical Affairs (Europe, Middle East, Africa)

  • Apr 2012 - Dec 2014

  Boudry (Neuchâtel), Switzerland (Celgene International Sàrl) Leadership of Medical Affairs function in the region for Celgene's products in Hematology-Oncology. Member of the European Operating Committee.

• Head of Medical Affairs (Europe, Middle East, Africa)

  • Jan 2010 - Mar 2012

  Boudry (Neuchâtel), Switzerland (Celgene International Sàrl) Leadership of Medical Affairs function in the region for Celgene's products in Hematology-Oncology. Member of the European Operating Committee.

• Medical Director Germany

  • May 2006 - Jan 2010

  Munich, Germany Member of national management team, co-operation with marketing and sales departments, co-ordination of medical department including medical affairs (incl. investigator-initiated trials, medical education), medical information and communication, drug safety and regulatory affairs (including risk management programs for thalidomide and lenalidomide), clinical research (Celgene-sponsored clinical trials. Launch of lenalidomide (2007, pre-launch access program 2006-2007), azacitidine (2009) and… Show more Member of national management team, co-operation with marketing and sales departments, co-ordination of medical department including medical affairs (incl. investigator-initiated trials, medical education), medical information and communication, drug safety and regulatory affairs (including risk management programs for thalidomide and lenalidomide), clinical research (Celgene-sponsored clinical trials. Launch of lenalidomide (2007, pre-launch access program 2006-2007), azacitidine (2009) and thalidomide (2009)



Bonn University

• Research Services
• 100 - 200 Employee

• Senior Attending Physician

  • Jul 2000 - Apr 2006

  Bonn Main areas of clinical work: Haematology-oncology (esp. acute myeloid leukaemia, myelodysplastic syndromes, multiple myeloma and lymphoma), infectious complications in neutropenic patients

• Physician

  • Aug 1988 - Jun 2000

  Bonn und Umgebung, Deutschland Training in Internal Medicine and Hematology-Oncology, main focus: Acute leukemias, multiple myeloma, autologous stem cell transplantation and infections in neutropenic patients.



Department of Internal Medicine, Krankenhaus Bethesda

• Physician

  • Jul 1987 - Jun 1988

  Freudenberg, Germany Internal Medicine Large clinic for patients with all types diabetes mellitus, incl. insulin pumps